[1]解旭品,方 欣,黄昌拼,等.紫杉醇药物涂层球囊治疗股腘动脉支架内再狭窄18例 [J].介入放射学杂志,2017,(06):544-547.
 XIE Xupin,FANG Xin,HUANG Changpin,et al.Drug- coated balloon with paclitaxel for in- stent restenosis of femoral popliteal artery: initial experience in 18 patients[J].journal interventional radiology,2017,(06):544-547.
点击复制

紫杉醇药物涂层球囊治疗股腘动脉支架内再狭窄18例


()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年06期
页码:
544-547
栏目:
临床研究
出版日期:
2017-06-25

文章信息/Info

Title:
Drug- coated balloon with paclitaxel for in- stent restenosis of femoral popliteal artery: initial experience in 18 patients
作者:
解旭品 方 欣 黄昌拼 刘永昌 徐 东 龙建云 林乃弓
Author(s):
XIE Xupin FANG Xin HUANG Changpin LIU Yongchang XU Dong LONG Jianyun LIN Naigong
Department of Vascular Surgery, First Municipal People’s Hospital, Hangzhou, Zhejiang Province 300001, China
关键词:
【关键词】 股腘动脉 支架内再狭窄 紫杉醇 药物涂层球囊
文献标志码:
A
摘要:
【摘要】 目的 探讨紫杉醇药物涂层球囊(DCB)治疗股腘动脉支架内再狭窄(ISR)的近期临床疗效。方法 2016年7月至2016年12月采用紫杉醇DCB治疗股腘动脉ISR 18例,其中男15例,女3例,平均年龄(72.7±9.8)岁;Fontaine ⅡB级9例,Ⅲ级8例,Ⅳ级1例;术前CTA证实ISR 3例,完全闭塞15例。所有患者开通病变后先予普通球囊预扩张,再用DCB后扩张,仍有限流性夹层或残余狭窄>50%则植入补救式支架。术后即刻造影评价血管通畅情况,术后第3日测定患肢ABI评估缺血改善情况。术后3个月随访再狭窄率、临床驱动靶病变血运重建(TLR)率、3个月内严重临床事件。结果 18例患者均成功开通病变血管,技术成功率100%。2例植入补救式支架。15例完成术后3个月随访,10例复查下肢动脉CTA或超声,靶病变再狭窄发生率为10%(1/10);临床驱动TLR率为6.67(1/15)。所有患者未发生操作相关严重临床事件。结论 紫杉醇DCB治疗腘股动脉ISR是安全、有效的选择。

参考文献/References:

[1] Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for 1esions in the sperficial femoral artery and proximal popliteal artery: twelve month resuIts from the RESILIENT randomized trial[J]. Circ Cardiovasc Interv, 2010, 3: 267- 276.
[2] 李 杨, 佟 铸, 谷涌泉. 股浅动脉支架内再狭窄的危险因素研究进展[J]. 介入放射学杂志, 2016, 25: 554- 558.
[3] 符伟国, 岳嘉宁. 股腘动脉段病变支架内再狭窄的腔内治疗策略分析[J]. 中华外科杂志, 2016, 54: 586- 590.
[4] Liistro F, Angioli P, Porto Ⅰ, et al. Paclitaxel- eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in- stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE- ISR study[J]. J Endovasc Ther, 2014, 21: 1- 8.
[5] Shammas NW, Shammas GA, Helou TJ, et al. Safety and 1- year revascularization outcome of SilverHawk atherectomy in treating in- stent restenosis of femoropopliteal arteries: a retrospective review from a single center[J]. Cardiovasc Revasc Med, 2012, 13: 224- 227.
[6] Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting[J]. J Am Coll Cardiol, 2012, 59: 16- 23.
[7] Loh JP, Barbash IM, Waksman R. The current status of drug- coated balloons in percutaneous coronary and peripheral inter- ventions[J]. EuroIntervention, 2013, 9: 979- 988.
[8] Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis[J].Circulation, 2004, 110: 810- 814.
[9] Stabile E, Virga V, Salemme L, et al. Drug- eluting balloon for treatment of superficial femoral artery in- stent restenosis[J]. J Am Coll Cardiol, 2012, 60: 1739- 1742.
[10] Laird JR, Singh GD. Drug- coated balloons as the new standard of care for femoropopliteal in- stent restenosis: FAIR assumption? [J]. Circulation, 2015, 132: 2198- 2200.
[11] Pieper CC, Thomas D, Nadal J, et al. Patient satisfaction after femoral arterial access site closure using the ExoSeal?誖vascular closure device compared to manual compression: a prospective intra- individual comparative study[J]. Cardiovasc Intervent Radiol, 2016, 39: 21- 27.

相似文献/References:

[1]郑辉,郭富强.Rho/Rho激酶信号通路与支架内再狭窄的研究[J].介入放射学杂志,2012,(02):172.
 ZHENG Hui,GUO Fu-qiang..Studies on Rho/Rho-kinase signalling pathways and in-stent restenosis[J].journal interventional radiology,2012,(06):172.
[2]岑锦明,熊卿圆,杨希立,等. 糖化血红蛋白与冠状动脉支架术后再狭窄的关系[J].介入放射学杂志,2012,(09):725.
 CEN Jin- ming,XIONG Qing- yuan,YANG Xi- li,et al. Relationship between glycated hemoglobin and restenosis after percutaneous coronary intervention procedure[J].journal interventional radiology,2012,(06):725.
[3]王海瑞,潘 涛,畅智慧,等.股腘动脉闭塞支架植入术后支架内再狭窄危险因素——贫血 [J].介入放射学杂志,2016,(11):1007.
 WANG Hai- rui,PAN Tao,CHANG Zhi- hui,et al.Anemia: a risk factor of in- stent restenosis after stenting for femoropopliteal artery occlusion[J].journal interventional radiology,2016,(06):1007.
[4]梁刚柱,张福先,魏海亮,等.下肢股腘动脉慢性完全闭塞病变分布及影响因素分析[J].介入放射学杂志,2015,(12):1052.
 LIANG Gang- zhu,ZHANG Fu- xian,WEI Hai- liang,et al.The distribution and related risk factors of femoro- popliteal artery chronic total occlusion lesions[J].journal interventional radiology,2015,(06):1052.
[5]李杨,佟铸,谷涌泉.股浅动脉支架内再狭窄的危险因素研究进展[J].介入放射学杂志,2016,(06):554.
 LI Yang,TONG Zhu,GU Yong-quan.Risk factors for superficial femoral artery in-stent restenosis: recent progress in research [J].journal interventional radiology,2016,(06):554.
[6]丁海霞,王富军,马红芳,等.脐带血干细胞移植对兔糖尿病后肢血管病变介入术后支架内再狭窄的影响[J].介入放射学杂志,2016,(08):695.
 DING Hai-xia,WANG Fu-jun,MA Hong-fang,et al.The effect of umbilical cord blood stem cell transplantation on the in-stent restenosis after intervention therapy for diabetic vascular diseases in experimental rabbits [J].journal interventional radiology,2016,(06):695.
[7]刘 蓉,马士新,赵 钢,等.紫杉醇药物涂层球囊扩张冠状动脉支架内再狭窄病变增加远期管腔面积 [J].介入放射学杂志,2017,(04):367.
 LIU Rong,MA Shixing,ZHAO Gang,et al.Long- term lumen area enlarged in coronary in- stent restenosis after the treatment of paclitaxel drug - coated balloon dilatation[J].journal interventional radiology,2017,(06):367.
[8]段润丹,谢 辉,吕 磊,等.股腘动脉支架断裂与支架内再狭窄相关性分析 [J].介入放射学杂志,2017,(06):496.
 DUAN Rundan,XIE Hui,Lv Lei,et al.The correlation between femoral popliteal artery stent fracture and in- stent restenosis[J].journal interventional radiology,2017,(06):496.
[9]曾书燚,王正东,陈 坚,等.药物洗脱球囊与药物洗脱支架治疗支架内再狭窄疗效比较 [J].介入放射学杂志,2017,(09):839.
 ZENG Shuyi,WANG Zhengdong,CHEN Jian,et al.Paclitaxel- eluting balloon versus drug- eluting stent for in- stent restenosis: comparative study of curative effect[J].journal interventional radiology,2017,(06):839.
[10]钟继明,黄学成,张景昌,等.冠状动脉雷帕霉素涂层支架植入术后支架内再狭窄临床预测因素探讨 [J].介入放射学杂志,2017,(10):874.
 ZHONG Jiming,HUANG Xuecheng,ZHANG Jingchang,et al.Investigation of the clinical predictors of in- stent restenosis after rapamycin- eluting coronary stent implantation[J].journal interventional radiology,2017,(06):874.

备注/Memo

备注/Memo:
(收稿日期:2017-03-07)
(本文编辑:边 佶)
更新日期/Last Update: 2017-06-13